{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:42:11Z","timestamp":1784612531597,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673510"],"award-info":[{"award-number":["81673510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703626"],"award-info":[{"award-number":["81703626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1608282"],"award-info":[{"award-number":["U1608282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Research Project of Education Department of Liaoning Province","award":["LK201611"],"award-info":[{"award-number":["LK201611"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11095-019-2579-6","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:03:43Z","timestamp":1549281823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Tong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shansen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"issue":"3","key":"2579_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.ajkd.2013.12.002","volume":"63","author":"S Samuel","year":"2014","unstructured":"Samuel S, Bitzan M, Zappitelli M, Dart A, Mammen C, Pinsk M, et al. Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014;63(3):354\u201362.","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"issue":"2","key":"2579_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11255-012-0205-1","volume":"45","author":"L Fan","year":"2013","unstructured":"Fan L, Liu Q, Liao Y, Li Z, Ji Y, Yang Z, et al. Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial. Int Urol Nephrol. 2013;45(2):459\u201368.","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"2579_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","volume":"43","author":"C Staatz","year":"2004","unstructured":"Staatz C, Tett S. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43(10):623\u201353.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"2579_CR4","first-page":"589","volume":"26","author":"S Shah","year":"2016","unstructured":"Shah S, Hafeez F. Comparison of efficacy of tacrolimus versus cyclosporine in childhood steroid-resistant nephrotic syndrome. J Coll Physicians Surg Pak. 2016;26(7):589\u201393.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"2579_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/11317550-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part II. Clin Pharmacokinet. 2010;49(4):207\u201321.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"2579_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00228-011-1083-7","volume":"67","author":"SN Wildt de","year":"2011","unstructured":"de Wildt SN, van Schaik RH, Soldin OP, Soldin SJ, Brojeni PY, van der Heiden IP, et al. The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation. Eur J Clin Pharmacol. 2011;67(12):1231\u201341.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"2579_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/FTD.0000000000000255","volume":"38","author":"N Picard","year":"2016","unstructured":"Picard N, Bergan S, Marquet P, van Gelder T, Wallemacq P, Hesselink DA, et al. Pharmacogenetic biomarkers predictive of the pharmacokinetics and pharmacodynamics of immunosuppressive drugs. Ther Drug Monit. 2016;38(Suppl 1):S57\u201369.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2579_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40262-013-0120-3","volume":"53","author":"DA Hesselink","year":"2014","unstructured":"Hesselink DA, Bouamar R, Elens L, van Schaik RH, van Gelder T. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2014;53(2):123\u201339.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"2579_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40262-016-0491-3","volume":"56","author":"F Andreu","year":"2017","unstructured":"Andreu F, Colom H, Elens L, van Gelder T, van Schaik RHN, Hesselink DA, et al. A new CYP3A5*3 and CYP3A4*22 cluster influencing tacrolimus target concentrations: a population approach. Clin Pharmacokinet. 2017;56(8):963\u201375.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"2579_CR10","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.transproceed.2010.08.001","volume":"42","author":"MA Lopez-Montenegro Soria","year":"2010","unstructured":"Lopez-Montenegro Soria MA, Kanter Berga J, Beltran Catalan S, Milara Paya J, Pallardo Mateu LM, Jimenez Torres NV. Genetic polymorphisms and individualized tacrolimus dosing. Transplant Proc. 2010;42(8):3031\u20133.","journal-title":"Transplant Proc"},{"issue":"9","key":"2579_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40262-013-0069-2","volume":"52","author":"K Ogasawara","year":"2013","unstructured":"Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F. Multidrug resistance-associated protein 2 (MRP2\/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clin Pharmacokinet. 2013;52(9):751\u201362.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"2579_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2217\/pgs.15.42","volume":"16","author":"RA Pulk","year":"2015","unstructured":"Pulk RA, Schladt DS, Oetting WS, Guan W, Israni AK, Matas AJ, et al. Multigene predictors of tacrolimus exposure in kidney transplant recipients. Pharmacogenomics. 2015;16(8):841\u201354.","journal-title":"Pharmacogenomics"},{"issue":"26","key":"2579_CR13","doi-asserted-by":"publisher","first-page":"17882","DOI":"10.1074\/jbc.M601302200","volume":"281","author":"X Gu","year":"2006","unstructured":"Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem. 2006;281(26):17882\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"2579_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/md10010242","volume":"10","author":"CL Liu","year":"2012","unstructured":"Liu CL, Lim YP, Hu ML. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells. Marine drugs. 2012;10(1):242\u201357.","journal-title":"Marine drugs"},{"issue":"4","key":"2579_CR15","first-page":"724","volume":"38","author":"T Zhang","year":"2018","unstructured":"Zhang T, Liu Y, Zeng R, Ling Q, Wen P, Fan J, et al. Association of donor small ubiquitin-like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after. Liver Transpl. 2018;38(4):724\u201332.","journal-title":"Liver Transpl"},{"issue":"10","key":"2579_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/TP.0b013e31826c3985","volume":"94","author":"KA Barraclough","year":"2012","unstructured":"Barraclough KA, Isbel NM, Lee KJ, Bergmann TK, Johnson DW, McWhinney BC, et al. NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. Transplantation. 2012;94(10):1025\u201332.","journal-title":"Transplantation"},{"issue":"6","key":"2579_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5414\/CPP48375","volume":"48","author":"R Velickovic-Radovanovic","year":"2010","unstructured":"Velickovic-Radovanovic R, Catic-Djordjevic A, Milovanovic JR, Djordjevic V, Paunovic G, Jankovic SM. Population pharmacokinetics of tacrolimus in kidney transplant patients. Int J Clin Pharmacol Ther. 2010;48(6):375\u201382.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"2579_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/aps.2014.110","volume":"36","author":"YX Lu","year":"2015","unstructured":"Lu YX, Su QH, Wu KH, Ren YP, Li L, Zhou TY, et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacol Sin. 2015;36(2):281\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"2579_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","volume":"48","author":"K Benkali","year":"2009","unstructured":"Benkali K, Premaud A, Picard N, Rerolle JP, Toupance O, Hoizey G, et al. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet. 2009;48(12):805\u201316.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2579_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","volume":"70","author":"E Storset","year":"2014","unstructured":"Storset E, Holford N, Midtvedt K, Bremer S, Bergan S, Asberg A. Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol. 2014;70(1):65\u201377.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2579_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1067\/mcp.2002.129304","volume":"72","author":"CE Staatz","year":"2002","unstructured":"Staatz CE, Willis C, Taylor PJ, Tett SE. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clin Pharmacol Ther. 2002;72(6):660\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2579_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/FTD.0b013e31824a67eb","volume":"34","author":"XQ Zhang","year":"2012","unstructured":"Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, et al. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Ther Drug Monit. 2012;34(2):126\u201333.","journal-title":"Ther Drug Monit"},{"key":"2579_CR23","doi-asserted-by":"crossref","unstructured":"Zhang H, Bu F, Li L, Jiao Z, Ma G, Cai W, et al. Prediction of drug-drug interaction between tacrolimus and principal ingredients of Wuzhi capsule in Chinese healthy volunteers using physiologically-based pharmacokinetic modelling. Basic Clin Pharmacol Toxicol. 2017.","DOI":"10.1111\/bcpt.12914"},{"issue":"1\u20132","key":"2579_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2010.01.025","volume":"389","author":"XL Qin","year":"2010","unstructured":"Qin XL, Bi HC, Wang XD, Li JL, Wang Y, Xue XP, et al. Mechanistic understanding of the different effects of Wuzhi tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of tacrolimus (FK506). Int J Pharm. 2010;389(1\u20132):114\u201321.","journal-title":"Int J Pharm"},{"issue":"4","key":"2579_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2125.2007.02922.x","volume":"64","author":"HW Xin","year":"2007","unstructured":"Xin HW, Wu XC, Li Q, Yu AR, Zhu M, Shen Y, et al. Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers. Br J Clin Pharmacol. 2007;64(4):469\u201375.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"2579_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1124\/dmd.112.050302","volume":"41","author":"H Wei","year":"2013","unstructured":"Wei H, Tao X, Di P, Yang Y, Li J, Qian X, et al. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats. Drug Metab Dispos. 2013;41(7):1398\u2013403.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"2579_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/FPC.0b013e32835fcbb6","volume":"23","author":"XC Zuo","year":"2013","unstructured":"Zuo XC, Ng CM, Barrett JS, Luo AJ, Zhang BK, Deng CH, et al. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. Pharmacogenet Genomics. 2013;23(5):251\u201361.","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"2579_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/bcp.12649","volume":"80","author":"CO Jacobo-Cabral","year":"2015","unstructured":"Jacobo-Cabral CO, Garcia-Roca P, Romero-Tejeda EM, Reyes H, Medeiros M, Castaneda-Hernandez G, et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. Br J Clin Pharmacol. 2015;80(4):630\u201341.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"2579_CR29","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1124\/dmd.111.041350","volume":"39","author":"A Grover","year":"2011","unstructured":"Grover A, Frassetto LA, Benet LZ, Chakkera HA. Pharmacokinetic differences corroborate observed low tacrolimus dosage in native American renal transplant patients. Drug metabolism and disposition: the biological fate of chemicals. 2011;39(11):2017\u20139.","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"1","key":"2579_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-200645010-00004","volume":"45","author":"WJ Sam","year":"2006","unstructured":"Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, et al. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Clin Pharmacokinet. 2006;45(1):59\u201375.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"2579_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/jcpt.12523","volume":"42","author":"HJ Zhang","year":"2017","unstructured":"Zhang HJ, Li DY, Zhu HJ, Fang Y, Liu TS. Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients. J Clin Pharm Ther. 2017;42(4):425\u201332.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"2579_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1365-2125.2000.00288.x","volume":"50","author":"WJ Sam","year":"2000","unstructured":"Sam WJ, Aw M, Quak SH, Lim SM, Charles BG, Chan SY, et al. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. Br J Clin Pharmacol. 2000;50(6):531\u201341.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2579_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN. PsN-toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Prog Biomed. 2005;79(3):241\u201357.","journal-title":"Comput Methods Prog Biomed"},{"issue":"2","key":"2579_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentre F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Prog Biomed. 2008;90(2):154\u201366.","journal-title":"Comput Methods Prog Biomed"},{"issue":"6","key":"2579_CR35","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1111\/j.1523-1755.2005.00352.x","volume":"67","author":"EM Scholten","year":"2005","unstructured":"Scholten EM, Cremers SC, Schoemaker RC, Rowshani AT, van Kan EJ, den Hartigh J, et al. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Kidney Int. 2005;67(6):2440\u20137.","journal-title":"Kidney Int"},{"issue":"10","key":"2579_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2165\/11535950-000000000-00000","volume":"49","author":"K Benkali","year":"2010","unstructured":"Benkali K, Rostaing L, Premaud A, Woillard JB, Saint-Marcoux F, Urien S, et al. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation. Clin Pharmacokinet. 2010;49(10):683\u201392.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2579_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.transproceed.2009.11.028","volume":"42","author":"J Larriba","year":"2010","unstructured":"Larriba J, Imperiali N, Groppa R, Giordani C, Algranatti S, Redal MA. Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients. Transplant Proc. 2010;42(1):257\u20139.","journal-title":"Transplant Proc"},{"issue":"1","key":"2579_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00228-012-1296-4","volume":"69","author":"N Han","year":"2013","unstructured":"Han N, Yun HY, Hong JY, Kim IW, Ji E, Hong SH, et al. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. Eur J Clin Pharmacol. 2013;69(1):53\u201363.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"2579_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/er.2001-0038","volume":"23","author":"SA Kliewer","year":"2002","unstructured":"Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev. 2002;23(5):687\u2013702.","journal-title":"Endocr Rev"},{"issue":"2","key":"2579_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/FTD.0000000000000134","volume":"37","author":"F Andreu","year":"2015","unstructured":"Andreu F, Colom H, Grinyo JM, Torras J, Cruzado JM, Lloberas N. Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients. Ther Drug Monit. 2015;37(2):246\u201355.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2579_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jcpt.12480","volume":"42","author":"P Chen","year":"2017","unstructured":"Chen P, Li J, Li J, Deng R, Fu Q, Chen J, et al. Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. J Clin Pharm Ther. 2017;42(1):93\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"2579_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13248","volume":"22","author":"F Hendijani","year":"2018","unstructured":"Hendijani F, Azarpira N, Kaviani M. Effect of CYP3A5*1 expression on tacrolimus required dose for transplant pediatrics: a systematic review and meta-analysis. Pediatr Transplant. 2018;22:e13248.","journal-title":"Pediatr Transplant"},{"issue":"5","key":"2579_CR43","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.phymed.2013.12.006","volume":"21","author":"XL Qin","year":"2014","unstructured":"Qin XL, Chen X, Zhong GP, Fan XM, Wang Y, Xue XP, et al. Effect of tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2014;21(5):766\u201372.","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"issue":"1","key":"2579_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/dmd.113.053892","volume":"42","author":"XL Qin","year":"2014","unstructured":"Qin XL, Chen X, Wang Y, Xue XP, Wang Y, Li JL, et al. In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A\/P-glycoprotein-mediated absorption and metabolism of tacrolimus. Drug metabolism and disposition: the biological fate of chemicals. 2014;42(1):193\u20139.","journal-title":"Drug metabolism and disposition: the biological fate of chemicals."},{"issue":"3","key":"2579_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5414\/CPP48224","volume":"48","author":"W Jiang","year":"2010","unstructured":"Jiang W, Wang X, Xu X, Kong L. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Ther. 2010;48(3):224\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"12","key":"2579_CR46","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00228-011-1075-7","volume":"67","author":"HW Xin","year":"2011","unstructured":"Xin HW, Li Q, Wu XC, He Y, Yu AR, Xiong L, et al. Effects of Schisandra sphenanthera extract on the blood concentration of tacrolimus in renal transplant recipients. Eur J Clin Pharmacol. 2011;67(12):1309\u201311.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2579_CR47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1124\/jpet.105.094342","volume":"316","author":"Y Mu","year":"2006","unstructured":"Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther. 2006;316(3):1369\u201377.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"2579_CR48","first-page":"1748","volume":"84","author":"GX Hao","year":"2018","unstructured":"Hao GX, Huang X, Zhang DF, Zheng Y, Shi HY. Li Y, et al. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome. 2018;84(8):1748\u201356.","journal-title":"Population pharmacokinetics of tacrolimus in children with nephrotic syndrome"},{"issue":"10","key":"2579_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1432-2277.2012.01513.x","volume":"25","author":"J Malyszko","year":"2012","unstructured":"Malyszko J, Oberbauer R, Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transplant international : official journal of the European Society for Organ Transplantation. 2012;25(10):1013\u201323.","journal-title":"Transplant international : official journal of the European Society for Organ Transplantation"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2579-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:27:37Z","timestamp":1580758057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2579"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2579-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"29 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}